The recent wave of federal workforce reductions is poised to have significant economic repercussions, with potential impacts extending far beyond the immediate job losses.
The federal 340B drug pricing program is failing to meet the needs of the vulnerable patients the program was intended to serve, while raising health care costs for employers and families, according to a new white paper.
The full billed price for a double lung transplant for a patient under 65 increased 81% between 2020 and this year, to $2.3 million, the firm estimates.
"When managers prioritize employee wellbeing, they could see improved employee morale, increased productivity, reduced absenteeism and lower turnover rates," says Joan Woodward, Executive Vice President of Public Policy for Travelers and President of the Travelers Institute.
The company put out a statement on Friday rejecting the allegations, but the Wall Street Journal article caused a 7.17% drop in the price of its stock.
The Biden administration’s agenda, which sought to provide Medicaid-funded emergency services to undocumented immigrants, has cost federal and state taxpayers more than $16.2 billion, according to Congressional Budget Office estimates.